Gsk Aktie - GSK

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

1.483,50

Gebot

1.483,00

Fragen

1.484,00

Volumen

714.902

1.476,50 Tagesbereich 1.491,00

1.282,50 52-Wochen-Bereich 1.820,00

Marktkapitalisierung

61,505B

Handelsende

1.477,50

Handelsbeginn

1.478,00

Letzte Trade

869

1483.33

(O)

Letzter Handelszeitpunkt

11:54:04

Finanzvolumen

10.600.248p

VWAP

1.482,7554

Durchschnittliches Volumen (3 Mio.)

8.910.151

Ausgegebene Aktien

4.145.945.481

Dividendenrendite

4.31%

Kurs-Gewinn-Verhältnis

23,88

Gewinn pro Aktie (EPS)

0,62

Erlöse

31,38B

Nettogewinn

2,58B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.gsk.com

Hauptsitz

London, Gbr

Gegründet

Gsk Plc is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker GSK. The last closing price for Gsk was 1.477,50p. Over the last year, Gsk shares have traded in a share price range of 1.282,50p to 1.820,00p.

Gsk currently has 4.145.945.481 shares in issue. The market capitalisation of Gsk is £61,26 billion. Gsk has a price to earnings ratio (PE ratio) of 23.88.

GSK PLC Transaction in Own Shares

GSK PLC 28 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...

GSK PLC Transaction in Own Shares

GSK PLC 27 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...

GSK PLC Transaction in Own Shares

GSK PLC 26 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...

GSK urinary tract infection drug Blujepa approved by US regulator

GSK on Tuesday said its urinary tract infection treatment gepotidacin, under the brand name Blujepa, has been approve ...

GSK PLC GSK uUTI treatment approved by US FDA

GSK PLC 25 March 2025 Issued: 25 March 2025, London UK Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract...

GSK PLC Transaction in Own Shares

GSK PLC 25 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...

GSK PLC Notice of AGM

GSK PLC 24 March 2025 GSK plc (the 'Company') Publication of Notice of Annual General Meeting 2025 The Company has today published on its...

GSK has application to expand use of mepolizumab accepted by EMA

GSK PLC on Monday said it has had an application to expand the use of mepolizumab for the treatment of chronic obstru ...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-30.5	-2.01453104359	1514	1529	1454.5	9846669	1493.24860221	DE
4	21	1.4358974359	1462.5	1560.5	1454.5	10840051	1508.05323478	DE
12	120	8.80088008801	1363.5	1560.5	1289	8910151	1448.04952974	DE
26	-42.5	-2.78505897772	1526	1560.5	1282.5	8540308	1419.50477061	DE
52	-218.1	-12.817348378	1701.6	1820	1282.5	7889091	1510.89782621	DE
156	-144.5	-8.87592137592	1628	1824.4	1282.5	8555397	1512.25933355	DE
260	13.7	0.932099605388	1469.8	1824.4	1190.8	8575602	1494.99503588	DE

GSK - Frequently Asked Questions (FAQ)

What is the current Gsk share price?

The current share price of Gsk is 1.483,50p

How many Gsk shares are in issue?

Gsk has 4.145.945.481 shares in issue

What is the market cap of Gsk?

The market capitalisation of Gsk is GBP 61,26B

What is the 1 year trading range for Gsk share price?

Gsk has traded in the range of 1.282,50p to 1.820,00p during the past year

What is the PE ratio of Gsk?

The price to earnings ratio of Gsk is 23,88

What is the cash to sales ratio of Gsk?

The cash to sales ratio of Gsk is 1,96

What is the reporting currency for Gsk?

Gsk reports financial results in GBP

What is the latest annual turnover for Gsk?

The latest annual turnover of Gsk is GBP 31,38B

What is the latest annual profit for Gsk?

The latest annual profit of Gsk is GBP 2,58B

What is the registered address of Gsk?

The registered address for Gsk is 79 NEW OXFORD STREET, LONDON, WC1A 1DG

What is the Gsk website address?

The website address for Gsk is www.gsk.com

Which industry sector does Gsk operate in?

Gsk operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
VRCIVerici Dx Plc	3,25p (30,00%)	3,32M
CRTXCrism Therapeutics Corporation	9,50p (26,67%)	104,65k
MET1Metals One Plc	17,50p (25,00%)	398,52k
CPAICapai Plc	0,255p (24,39%)	292,46M
PFCPetrofac Limited	5,995p (24,38%)	3,51M
URUUru Metals Limited	4,75p (-44,12%)	948,62k
GCMGcm Resources Plc	2,85p (-20,83%)	8,69M
MDZMediazest Plc	0,0575p (-14,81%)	10,41M
THRUThruvision Group Plc	1,50p (-14,29%)	1,74M
WBIWoodbois Limited	0,0525p (-12,50%)	18,05M
PREMPremier African Minerals Limited	0,035p (20,69%)	4,44B
CHPCaledonian Holdings Plc	0,0025p (0,00%)	1,99B
CPAICapai Plc	0,255p (24,39%)	292,46M
UKOGUk Oil & Gas Plc	0,01325p (-10,47%)	272,03M
ALBAAlba Mineral Resources	0,015p (3,45%)	170,8M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Gsk Plc (GSK)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Gsk Plc

GSK Neueste Nachrichten

GSK PLC Transaction in Own Shares

GSK PLC Transaction in Own Shares

GSK PLC Transaction in Own Shares

GSK urinary tract infection drug Blujepa approved by US regulator

GSK PLC GSK uUTI treatment approved by US FDA

GSK PLC Transaction in Own Shares

GSK PLC Notice of AGM

GSK has application to expand use of mepolizumab accepted by EMA

GSK PLC Transaction in Own Shares

GSK PLC Transaction in Own Shares

GSK PLC Transaction in Own Shares

GSK urinary tract infection drug Blujepa approved by US regulator

GSK PLC GSK uUTI treatment approved by US FDA

GSK PLC Transaction in Own Shares

GSK PLC Notice of AGM

GSK has application to expand use of mepolizumab accepted by EMA

GSK - Frequently Asked Questions (FAQ)

Beweger

GSK Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Gsk Plc (GSK) Börsenkurse

Gsk Plc (GSK)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Gsk Plc

GSK Neueste Nachrichten

GSK PLC Transaction in Own Shares

GSK PLC Transaction in Own Shares

GSK PLC Transaction in Own Shares

GSK urinary tract infection drug Blujepa approved by US regulator

GSK PLC GSK uUTI treatment approved by US FDA

GSK PLC Transaction in Own Shares

GSK PLC Notice of AGM

GSK has application to expand use of mepolizumab accepted by EMA

GSK PLC Transaction in Own Shares

GSK PLC Transaction in Own Shares

GSK PLC Transaction in Own Shares

GSK urinary tract infection drug Blujepa approved by US regulator

GSK PLC GSK uUTI treatment approved by US FDA

GSK PLC Transaction in Own Shares

GSK PLC Notice of AGM

GSK has application to expand use of mepolizumab accepted by EMA

GSK - Frequently Asked Questions (FAQ)

Beweger

GSK Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen